BioLargo’s subsidiary Clyra Medical secures over $1 million in direct investments to finalize the acquisition of the breakthrough stem cell therapy technology SkinDisc

BIOLARGO’S SUBSIDIARY CLYRA MEDICAL SECURES OVER $1 MILLION IN DIRECT INVESTMENTS TO FINALIZE THE ACQUISITION OF THE BREAKTHROUGH STEM CELL THERAPY TECHNOLOGY SKINDISC We’re delighted to share this news from our partner, BioLargo about a recent infusion of new investment capital and acquisition of breakthrough stem cell therapy technology called SkinDiscTM by their partially owned subsidiary, Clyra Medical Technologies, Inc. The cutting-edge SkinDiscTM technology uses a homogeneous cocktail to generate a cell-rich bio gel that supports the healing of chronic wounds. To date, the technology has been deployed clinically in over 250 patient cases with no adverse side effects, and successfully aided in the salvage of limbs that otherwise may have Read Full Blog Post >

Support the cause, spread the love, and share the good...

Investors and Businesses – Our Best Chance to Avert Climate Change?

This article was originally published on the Turnkey Group website and in Eco-Business. The Disruptive Factory is proud to partner with Turnkey Group, and we support their world-class sustainability reporting and analytics platform that helps investors and organizations optimize environmental, social and governance (ESG) integration in their existing portfolio and future investment opportunities. The recent IPCC report drove home the urgency of taking action to prevent the worst impacts of climate change from happening. Will the finance and business sectors, who have the ability to act faster and more efficiently than public institutions, step up? Over the last decade, climate change has increasingly gained exposure as a topic that impacts every single person on Read Full Blog Post >

Support the cause, spread the love, and share the good...